Preventive Effect of Boron-based Gel on Radiation Dermatitis

NCT04239560 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 257

Last updated 2020-01-28

No results posted yet for this study

Summary

Preventive Effect of Boron-based Gel on Radiation Dermatitis

Conditions

  • Radiodermatitis

Interventions

DRUG

Boron-based Gel (Fibore)

During each radiotherapy session, 15 minutes before radiotherapy, the gel used and patients followed up.

DRUG

Placebos

During each radiotherapy session, 15 minutes before radiotherapy, the Placebo gel which be free of any chemical used and patients followed up.

Sponsors & Collaborators

  • Tabriz University of Medical Sciences

    lead OTHER

Principal Investigators

  • Farshad SeyedNejad, MD · Tabriz University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-04
Primary Completion
2019-09-21
Completion
2019-12-21

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04239560 on ClinicalTrials.gov